Table 1.
Genotype | Phenotype | References |
---|---|---|
Tie1−/− | Lethality between E13.5 and birth; loss of vascular integrity and maturity; widespread edema and hemorrhaging | [19] |
Tie2−/− | Embryonic lethality between E9.5 and E12.5; vessel remodeling defects in the brain and plexus of the yolk sac; severe heart defects; decreased numbers of vascular ECs; poorly organized vessels with fewer branches and less pericyte coverage | [3,16,17,18,22] |
Tie1−/−; Tie2−/− | Embryonic lethality at E10.5; vasculature develops normally; cardiovascular defects; loss of vascular integrity and maturity | [21] |
Ang1−/− | Embryonic lethality between E11 and E12.5; growth-retarded hearts; collapsed endocardium and endothelial lining in the atria; immature primary plexus; decreased pericyte coverage of vessels | [16] |
Ang2−/− | Lethality by postnatal day P14; chylous ascites develop a few days after birth; severe vascular defects including collapsed endocardial lining from the myocardium and disruption of vascular integrity; impaired response to inflammatory challenges | [23,24] |